Literature DB >> 20699473

B cell receptor signaling: picky about PI3Ks.

Jose J Limon1, David A Fruman.   

Abstract

The B cell receptor (BCR) and the pre-BCR control cell fate at many stages of B cell development, survival, and antigen response. Most of these processes require the activation of phosphatidylinositol 3-kinase (PI3K). Previous work has pointed to p110delta as the key catalytic isoform of PI3K for many B cell responses. A study of mice with different combinations of PI3K mutations confirms the central role of p110delta in agonist-mediated signaling, while identifying an unexpected function for the p110alpha isoform in tonic signaling by the pre-BCR and mature BCR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20699473     DOI: 10.1126/scisignal.3134pe25

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  5 in total

1.  Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

Authors:  Christian Grommes; Alessandro Pastore; Nicolaos Palaskas; Sarah S Tang; Carl Campos; Derrek Schartz; Paolo Codega; Donna Nichol; Owen Clark; Wan-Ying Hsieh; Dan Rohle; Marc Rosenblum; Agnes Viale; Viviane S Tabar; Cameron W Brennan; Igor T Gavrilovic; Thomas J Kaley; Craig P Nolan; Antonio Omuro; Elena Pentsova; Alissa A Thomas; Elina Tsyvkin; Ariela Noy; M Lia Palomba; Paul Hamlin; Craig S Sauter; Craig H Moskowitz; Julia Wolfe; Ahmet Dogan; Minhee Won; Jon Glass; Scott Peak; Enrico C Lallana; Vaios Hatzoglou; Anne S Reiner; Philip H Gutin; Jason T Huse; Katherine S Panageas; Thomas G Graeber; Nikolaus Schultz; Lisa M DeAngelis; Ingo K Mellinghoff
Journal:  Cancer Discov       Date:  2017-06-15       Impact factor: 39.397

Review 2.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

3.  Class IA PI3K inhibition inhibits cell growth and proliferation in mantle cell lymphoma.

Authors:  Yoko Tabe; Linhua Jin; Marina Konopleva; Masato Shikami; Shinya Kimura; Michael Andreeff; Mark Raffeld; Takashi Miida
Journal:  Acta Haematol       Date:  2013-09-19       Impact factor: 2.195

Review 4.  The multifaceted role of PIP2 in leukocyte biology.

Authors:  Loretta Tuosto; Cristina Capuano; Michela Muscolini; Angela Santoni; Ricciarda Galandrini
Journal:  Cell Mol Life Sci       Date:  2015-08-12       Impact factor: 9.261

Review 5.  For Better or Worse: The Potential for Dose Limiting the On-Target Toxicity of PI 3-Kinase Inhibitors.

Authors:  Christina M Buchanan; Kate L Lee; Peter R Shepherd
Journal:  Biomolecules       Date:  2019-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.